Literature DB >> 19932200

Multiple sclerosis: geoepidemiology, genetics and the environment.

Ron Milo1, Esther Kahana.   

Abstract

Multiple sclerosis (MS) is a chronic immune-mediated demyelinating disease of the central nervous system characterized by relapses and remissions. The risk of acquiring this complex disease is associated with exposure to environmental factors in genetically susceptible individuals. The epidemiology of MS has been extensively studied. We review the geographic epidemiology of the disease, the influence of immigration, age at immigration, clustering and epidemics. Various presumptive risk factors are discussed such as ultraviolet radiation, vitamin D, Epstein-Barr virus and infectious mononucleosis, other infectious agents and non-infectious factors. Two different hypotheses, the hygiene hypothesis and the prevalence hypothesis, were proposed to explain these environmental risk factors for MS. The epidemiological data, combined with pathological and immunological data, may contribute to the debate whether MS is an autoimmune disease, a latent or persistent viral disease, or a neurodegenerative disease. 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19932200     DOI: 10.1016/j.autrev.2009.11.010

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  156 in total

Review 1.  The therapeutic potential of epigenetics in autoimmune diseases.

Authors:  Maria De Santis; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

Review 2.  Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop.

Authors:  Frederick W Miller; Lars Alfredsson; Karen H Costenbader; Diane L Kamen; Lorene M Nelson; Jill M Norris; Anneclaire J De Roos
Journal:  J Autoimmun       Date:  2012-06-25       Impact factor: 7.094

3.  The persistent challenge of lupus nephritis.

Authors:  Guido Valesini; Fabrizio Conti
Journal:  Clin Rev Allergy Immunol       Date:  2011-06       Impact factor: 8.667

4.  Reproductive immunology: a focus on the role of female sex hormones and other gender-related factors.

Authors:  Elena Peeva
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

Review 5.  Oligodendrocyte regeneration: Its significance in myelin replacement and neuroprotection in multiple sclerosis.

Authors:  Kelly A Chamberlain; Sonia E Nanescu; Konstantina Psachoulia; Jeffrey K Huang
Journal:  Neuropharmacology       Date:  2015-10-22       Impact factor: 5.250

Review 6.  Regulation of the immune system by biodiversity from the natural environment: an ecosystem service essential to health.

Authors:  Graham A Rook
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-23       Impact factor: 11.205

7.  Pericytes modulate myelination in the central nervous system.

Authors:  Patrick O Azevedo; Isadora F G Sena; Julia P Andreotti; Juliana Carvalho-Tavares; José C Alves-Filho; Thiago M Cunha; Fernando Q Cunha; Akiva Mintz; Alexander Birbrair
Journal:  J Cell Physiol       Date:  2018-03-01       Impact factor: 6.384

8.  Prevalence of Multiple Sclerosis in the Middle Black Sea Region of Turkey and Demographic Characteristics of Patients.

Authors:  Neslihan Akdemir; Murat Terzi; Nilden Arslan; Musa Onar
Journal:  Noro Psikiyatr Ars       Date:  2017-03-01       Impact factor: 1.339

9.  miR-145 and miR20a-5p Potentially Mediate Pleiotropic Effects of Interferon-Beta Through Mitogen-Activated Protein Kinase Signaling Pathway in Multiple Sclerosis Patients.

Authors:  Naeim Ehtesham; Fariborz Khorvash; Majid Kheirollahi
Journal:  J Mol Neurosci       Date:  2016-10-17       Impact factor: 3.444

10.  Efficacy of N-Acetylserotonin and Melatonin in the EAE Model of Multiple Sclerosis.

Authors:  Jie Wen; Prasanth S Ariyannur; Rachel Ribeiro; Mikiei Tanaka; John R Moffett; Batool F Kirmani; Aryan M A Namboodiri; Yumin Zhang
Journal:  J Neuroimmune Pharmacol       Date:  2016-08-25       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.